Compliance Information
ESMO 2022 is organised by the European Society for Medical Oncology (based in Lugano, Switzerland). The congress is provided to international HCPs with a majority from Europe and is following the EFPIA guidance/code.
On-site
Participants fully registered to the congress, visitors wearing the visitors’ badge, exhibitors wearing the exhibitor badge and agencies wearing the Industry Satellite badge have the right to attend satellite symposia sessions.
For ESMO 2022, different badge coloured stripes will be used in order to be able identifying delegates as prescribers or non-prescribers. This decision has been taken to comply with prescription-only medicines promotional legislation, both European and national. (i) Delegates attending the Congress will be responsible when deciding which parts or areas of the congress they access to or visit, and (ii) By previously identifying their profile, pharmaceutical companies will be responsible when deciding how they engage or interact with participants, according to European legislation and any applicable code of practice.
Online
Satellite symposia sessions will be accessible for all registered delegates, however companies may add a disclaimer on top of their Satellite Symposium Virtual Space (see paragraph 5.2).